AZIYO BIOLOGICS INC-CLASS A (AZYO)
US05479K1060 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -33.95M | -32.90M | -24.83M | -21.83M | -11.94M | |||
| Depreciation Amortization | 3.77M | 3.73M | 3.73M | 3.86M | 3.86M | |||
| Change In Working Capital | 7.85M | 5.71M | 2.38M | -2.67M | -470.00K | |||
| Interest Paid | 5.42M | 5.48M | 4.98M | 5.11M | 4.40M | |||
| Taxes Paid | N/A | N/A | N/A | 30.00K | 30.00K | |||
| Other non cash items | 4.01M | 2.02M | 3.28M | 7.00M | 1.33M | |||
| OPERATING CASH FLOW | -18.32M | -21.43M | -15.45M | -13.63M | -7.23M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -518.00K | -540.00K | -369.00K | -640.00K | -580.00K | |||
| INVESTING CASH FLOW | -518.00K | -540.00K | -369.00K | -640.00K | -580.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 3.27M | 1.62M | -4.53M | 6.98M | 9.01M | |||
| Stock Issued/Repurchased | 10.44M | 10.48M | 13.99M | 46.87M | 20.00K | |||
| Other Financing Activity | -2.09M | -3.57M | -2.75M | -2.65M | -1.05M | |||
| FINANCING CASH FLOW | 11.62M | 8.54M | 6.71M | 51.21M | 7.98M | |||
| CHANGE IN CASH | -7.21M | -13.44M | -9.10M | 36.94M | 170.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.32M | -21.43M | -15.45M | -13.63M | -7.23M | |||
| Capital Expenditure | -518.00K | -540.00K | -369.00K | -640.00K | -580.00K | |||
| FREE CASH FLOW | -18.83M | -21.97M | -15.81M | -14.27M | -7.81M | |||
All data in USD